𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Low Frequency of Autoantibodies to Islet Cell, Glutamic Acid Decarboxylase, and Second-Islet Antigen in Patients with Gestational Diabetes Mellitus : A Follow-up Study

✍ Scribed by A. LAPOLLA; D. FEDELE; B. PEDINI; M. G. DAL FRÀ; M. SANZARI; M. MASIN; R. ZANCHETTA; C. BETTERLE

Book ID
110108333
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
675 KB
Volume
958
Category
Article
ISSN
0890-6564

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Elimination of islet cell antibodies and
Elimination of islet cell antibodies and glutamic acid decarboxylase antibodies II in a patient with newly diagnosed insulin-dependent diabetes mellitus
✍ W. O. Richter; M. G. Donner; P. Schwandt 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Islet cell antibodies and glutamic acid decarboxylase II (GAD II) antibodies have been discussed in the autoimmune pathogenesis of insulin-dependent diabetes mellitus (IDDM). Hence, immunosuppressants, intravenous immunoglobulins, and plasmapheresis have been used in an effort to modulate autoimmune

Islet cell and insulin autoantibodies in
Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of Type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study
✍ C. Betterle; F. Presotto; B. Pedini; L. Moro; R. S. Slack; F. Zanette; R. Zanche 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 530 KB

To evaluate the behaviour and predictive value of islet cell and insulin autoantibodies in patients with organ-specific autoimmune diseases, we followed 21 non-diabetic subjects for a mean period of 84 +/- 27 months. Ten patients were persistently seropositive for complement-fixing islet cell antibo